Children and adolescents with venous thromboembolism, particularly children aged 4 years or younger, face a higher risk for ...
Restraint may be a modifiable risk factor, but more robust estimates of baseline risk are needed Hospital associated venous thromboembolism (VTE), defined as pulmonary embolism and deep vein ...
Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts Using retrospective data from ...
Hospitalised patients with chronic liver disease may have an increased risk of developing venous thromboembolism (VTE; deep vein thrombosis [DVT] and/or pulmonary embolism [PE]). Findings suggest that ...
(HealthDay)—The rate of recurrent venous thromboembolism is higher than expected for patients with subsegmental pulmonary embolism managed without anticoagulation who do not have proximal deep venous ...
23andMe research cohort analysis finds higher risk of venous thromboembolism and pulmonary embolism for people with sickle cell trait, yet relatively low risk of blood clotting overall (WASHINGTON – ...
The American Society of Hematology (ASH) and the International Society on Thrombosis and Hemostasis (ISTH) released new and updated clinical practice guidelines for the treatment of pediatric venous ...
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...
A research team from the Complexity Science Hub and MedUni Vienna analyzed 180,034 patients with diabetes mellitus and found evidence that women are at higher risk of venous thromboembolism than men - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results